References
- Coronavirus Research center. Johns Hopkins University of Medicine [Internet]; [cited 2020 Nov 9]. Available from: https://coronavirus.jhu.edu/map.html.
- Morris M, Nolte E, Aggarwal A, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020;21(8):1023–1034.
- London JW, Fazio-Eynullayeva E, Palchuk MB, et al. Effects of the COVID-19 pandemic on cancer-related patient encounters. JCO Clin Cancer Inform. 2020;(4):657–665.
- Borobia A, Carcas A, Arnalich F, et al. A cohort of patients with COVID-19 in a major teaching hospital in europe. J Clin Med. 2020;9(6):1733.
- Vijenthira A, Gong IY, Fox TA, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136(25):2881–2892.
- Núñez-Torrón C, García-Gutiérrez V, Tenorio-Núñez MC, et al. Poor outcome in patients with acute leukemia on intensive chemotherapy and COVID-19. Bone Marrow Transplant. 2021;56(1):267–269.
- de la Cruz-Benito B, Lázaro-del Campo P, Ramírez-López A, et al. Managing the front-line treatment for diffuse large B cell lymphoma and high-grade B cell lymphoma during the COVID-19 outbreak. Br J Haematol. 2020;191(3):386–389.
- Zeidan AM, Boddu PC, Patnaik MM, et al. Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts. Lancet Haematol. 2020;7(8):e601–e612.
- Burnett AK, Russell NH, Hills RK, et al. Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial. J Clin Oncol. 2013;31(27):3360–3368.
- Ardura M, Hartley D, Dandoy C, et al. Addressing the impact of the Coronavirus Disease 2019 (COVID-19) pandemic on hematopoietic cell transplantation: learning networks as a means for sharing best practices. Biol Blood Marrow Transplant. 2020;26(7):e147–e160.
- Sanchez-Pina JM, Rodríguez Rodriguez M, Castro Quismondo N, et al. Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies. Eur J Haematol. 2020;105(5):597–607.
- García-Suárez J, De La Cruz J, Cedillo Á, et al. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study. J Hematol Oncol. 2020;13(1):133.
- ASH Research Collaborative COVID-19 Registry [Internet]; [cited 2020 Nov 9]. Available from: https://www.ashresearchcollaborative.org/s/covid-19-registry.
- El-Sharkawi D, Iyengar S. Haematological cancers and the risk of severe COVID-19: exploration and critical evaluation of the evidence to date. Br J Haematol. 2020;190(3):336–345.
- Wilde L, Isidori A, Keiffer G, et al. Caring for AML patients during the COVID-19 crisis: an american and italian experience. Front Oncol. 2020;10:1689.